Eli Lilly (LLY) is up 6.3%, or $48.00 to $805.54.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Novo Nordisk (NYSE:NVO) Slides as Weight-Loss Drug Trial Misses Expectations
- Morning Movers: Lilly rises, Novo Nordisk falls following CagriSema trial data
- Eli Lilly Stock Soars as FDA Ends Weight Loss Drug Shortage
- Novo obesity data ‘nearly a best-case’ for Eli Lilly, says Citi
- BofA says Hims’ semaglutide compounding opportunity may be shorter than expected